Why It's Relevant
“Clinicians are increasingly asked to recommend or integrate apps into care, and our results suggest which features may help sustain patient engagement,” the authors wrote. “Moreover, knowledge of typical adherence benchmarks can help clinicians set realistic expectations with patients.”
By the Numbers
Sample: 79 randomized clinical trials testing mental health smartphone apps (39 for depression, 26 for anxiety, and 14 for anxiety/depression).
Uptake: 92% of users activated the app or logged in at least once.
Adherence: 62% completed the minimum amount of time or content required in the trial.
Attrition: 19% of participants didn’t complete a post-trial follow-up.
The Other Side
Only 25% of trials reported adherence, with lower-adherence trials possibly underrepresented. Thus, pooled adherence rate may be overestimated. Clinical trial participants are typically more motived than the general population, which may also inflate findings.
What’s Next
“Future research may benefit from exploring how emerging technologies, such as generative artificial intelligence, can support the development of app features that show early promise for improving engagement,” the authors wrote. “The digital mental health field is uniquely positioned for rapid iteration and innovation, with novel technology-enabled solutions increasingly within reach.”
Related Info:
“Rejoyn: First App Cleared by FDA for Depression; Cost, Efficacy Unclear”
(Image: Getty Images/iStock/dikushin)